BindingDB logo
myBDB logout

BDBM144757 US8952128, 15

SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1

InChI Key: InChIKey=HAWXIKWHZCZBIT-TZDZZSAGSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 144757   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Somatostatin receptor type 2


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

0.0200 -14.6n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 5


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

0.0800 -13.8n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
Somatostatin receptor type 1


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/m1/s1
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

64.4 -9.80n/an/an/an/an/a7.625



Ipsen Pharma S.A.S.

US Patent


Assay Description
Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair
D(2) dopamine receptor


(Homo sapiens (Human))
BDBM144757
PNG
(US8952128, 15)
Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O)NC[C@H](Cc1ccc(O)cc1)NC(=O)CS(=O)C[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1
Show InChI InChI=1S/C86H110N18O12S/c1-52(105)77-85(115)102-70(41-53-17-5-3-6-18-53)78(108)91-35-14-12-24-67(95-48-60(39-55-28-30-61(106)31-29-55)96-75(107)51-117(116)50-57-40-64-63-22-15-26-66-76(63)59(47-94-66)45-74(64)104(2)49-57)79(109)97-69(27-16-36-92-86(88)89)80(110)99-71(42-54-19-7-4-8-20-54)82(112)100-72(43-56-32-37-90-38-33-56)83(113)101-73(44-58-46-93-65-23-10-9-21-62(58)65)84(114)98-68(81(111)103-77)25-11-13-34-87/h3-10,15,17-23,26,28-33,37-38,46-47,52,57,60,64,67-74,77,93-95,105-106H,11-14,16,24-25,27,34-36,39-45,48-51,87H2,1-2H3,(H,91,108)(H,96,107)(H,97,109)(H,98,114)(H,99,110)(H,100,112)(H,101,113)(H,102,115)(H,103,111)(H4,88,89,92)/t52-,57-,60+,64-,67-,68+,69+,70+,71+,72+,73-,74-,77+,117?/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

149n/an/an/an/an/an/a7.6n/a



Ipsen Pharma S.A.S.

US Patent


Assay Description
The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...


US Patent US8952128 (2015)


BindingDB Entry DOI: 10.7270/Q2057DNG
More data for this
Ligand-Target Pair